
In re Acetaminophen – ASD-ADHD Products Liability Litigation
2022年10月5日 · The plaintiffs in this multidistrict litigation ("MDL") assert that children developed autism spectrum disorder and/or attention deficit/hyperactivity disorder as a result of in utero exposure to acetaminophen. The MDL docket number for this action is 1:22-md-3043 (DLC). The MDL docket includes all the filings and orders issued in the MDL.
IN RE: ACETAMINOPHEN - ASD/ADHD MDL No. 3043. PRODUCTS LIABILITY LITIGATION. TRANSFER ORDER . Before the Panel: ∗ Plaintiff in one action (Thompson) moves under 28 U.S.C. § 1407 to centralize this litigation in the Northern District of California , alternatively, the District of or Minnesota.
IN RE: Acetaminophen - ASD/ADHD Products Liability Litigation MDL …
2022年6月10日 · ( #1 in MDL No. 3043) -- Identifying Corporate Parent Walgreens Boots Alliance, Inc. for Walgreen Co. (Incorrectly named as Walgreens Co. and Walgreens Boots Alliance, Inc.) (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 3043, CAC/2:22-cv-03864, MOW/4:22-cv-00366, MOW/4:22-cv-00369, MOW/4:22-cv-00370, NV/2: ...
ASD/ADHD Prods. Liab. Litig., MDL 3043 - Casetext
2022年10月14日 · Read In re Acetaminophen - ASD/ADHD Prods. Liab. Litig., MDL 3043, see flags on bad law, and search Casetext’s comprehensive legal database
litigation (“MDL”) in which plaintiffs allege that in utero exposure to acetaminophen causes autism spectrum disorder (“ASD”) and attention-deficit/hyperactivity disorder (“ADHD”) in
Acetaminophen ASD ADHD Products Liability Litigation
This document discusses the case MDL No. 3043 related to acetaminophen and its potential link to autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD). It provides insights into the ongoing litigation involving multiple defendants and plaintiffs.
IN RE: Acetaminophen - ASD/ADHD Products Liability Litigation ( MDL …
Citation: IN RE: Acetaminophen - ASD/ADHD Products Liability Litigation, MDL No. 3043, (J.P.M.L.) Date Filed: June 10, 2022. Date of Last Known Filing: March 5, 2024. MLD Status: Transferred.
IN RE: Acetaminophen - ASD/ADHD Products Liability Litigation
2012年1月20日 · Case docket: IN RE: Acetaminophen - ASD/ADHD Products Liability Litigation, MDL No. 3043 in Judicial Panel On Multidistrict Litigation, Denise L. Cote presiding, last filing 01/10/2023, filed 06/10/2022.
In re: Acetaminophen - ASD/Adhd Products Liability Litigation, MDL 3043 …
2022年10月14日 · Read In re: Acetaminophen - ASD/Adhd Products Liability Litigation, MDL 3043, see flags on bad law, and search Casetext’s comprehensive legal database
2023年1月9日 · Products Liability Litigation, MDL No. 3043, on December 16, 2022: The Master Long Form Complaint and Jury Demand Against Johnson & Johnson Consumer Inc. (DE 276).
- 某些结果已被删除